Covid 19 Vaccine for Pfizer-BioNTech: Permit procured in India

Covid 19 Vaccine for Pfizer-BioNTech: Permit procured in India

While the corona vaccine is being given to citizens in Russia and Britain, now there is a big news about the corona vaccine in India as well.

New Delhi, Dec 6 (IANS) While corona vaccines are being given to citizens in Russia and Britain, there is a lot of news in India about the corona vaccine. The corona vaccine, developed by the drug manufacturer Pfizer, has been sought by DCGI for emergency use. The company has applied for approval for the emergency use of the Corona vaccine. The vaccine has been approved in the UK and Bahrain and is now in India.

In an application filed with the drug regulator, the company has sought permission to import and use in India in case of an emergency. In addition, a special provision of the Drugs and Clinical Trial Rules 2019 has been requested to exempt from clinical trials considering the population of India. The application was filed on December 4 and all eyes are now on whether it will be approved.

Pfizer, a company that is 95 percent effective against coronavirus, and BioNtech SE’s Corona Lashi have been approved for emergency use in the UK. The vaccine will be available from next week. This vaccine is based on synthetic mRNA. This produces proteins in the human body which then develop protective antibodies.

The coronavirus vaccine, a joint venture between US pharma company Pfizer and German company Bioentech, has been approved in the UK. The vaccine will be given to people in Britain next week.

Hours after Britain’s reassuring news, Putin ordered the Russian government to carry out large-scale vaccinations, and by the end of 2020, the world is expected to be in a state of great relief.

Covid 19 Vaccine for Pfizer-BioNTech: Permit procured in India

c9375be852261e7d14e7598670cdf542?s=130&d=retro&r=g - Covid 19 Vaccine for Pfizer-BioNTech: Permit procured in India
Rajat Singhhttps://bioinformaticsindia.com
Rajat Singh is the chief Author at Bioinformatics India, he has been writing for the past 3 years and has a special interest in SEO, Technology, Health, Life Sciences and gaming.

Get in Touch

Comments are closed.

Related Articles

Get in Touch

231FansLike
544FollowersFollow
75FollowersFollow
55FollowersFollow
243SubscribersSubscribe
Get new posts by email:

Latest Posts